The Science of Nicotine Withdrawal and How to Beat Cravings

Despite nicotine's benefits of increasing alertness and offering momentary feelings of pleasure, using tobacco products have health risks. Nicotine has a strong withdrawal syndrome that occurs when a person who has developed physical dependence on nicotine abruptly reduces or stops use. Many who stop nicotine whether delivered by cigarette, vape, or even nicotine replacement products may feel the uncomfortable sensation of withdrawal. This article will explain withdrawal, which is rooted in long-term adaptations of nicotinic acetylcholine receptors (nAChRs) and broader neural networks regulating reward, mood, attention, and autonomic function.

Smoke from a vape pen

How Nicotine Affects the Brain

Nicotine primarily acts on nicotinic acetylcholine receptors (nAChRs), which are found throughout the brain and peripheral nervous system. Acetylcholine is a critically important neurotransmitter that is involved in attention, arousal, involuntary muscle movement, heart rate regulation, digestion, and many more functions. Nicotine has the ability to bind to nicotinic acetycholine receptors and chronic nicotine exposure causes:

• Upregulation (increase) of nAChRs: Paradoxically, nicotine increases the number of nicotinic receptors on neurons. This is thought to be a compensatory response to receptor desensitization caused by continuous stimulation.

• Adaptation of the dopamine system in the brain: Nicotine stimulates the mesolimbic dopamine pathway (ventral tegmental area to the nucleus accumbens). This pathway is commonly known as the "reward center" and it is theorized that this area reinforces addictive behaviors. Over time, the brain relies on nicotine to maintain baseline dopamine levels.

• Changes in norepinephrine, serotonin, glutamate, and GABA activity, contributing to attention, emotional, and stress-response effects.

When nicotine is removed, these systems become temporarily dysregulated. Upregulated receptors lack their usual agonist (nicotine), which leads to less neurotransmission in pathways that normally regulate reward, focus, mood, and arousal. These changes can lead to nicotine withdrawal.

Common Symptoms of Nicotine Withdrawal

Nicotine withdrawal is recognized as a powerful syndrome, leading to relapse despite how motivated a person may be to quit smoking or vaping. Withdrawal may include physical, psychological, and cognitive symptom, which often peak within 2 to 3 days and improve over several weeks. However, cravings can persist longer. The following are common nicotine withdrawal symptoms:

Psychological and cognitive symptoms

• Irritability, frustration, or anger

• Anxiety or nervousness

• Depressed mood or anhedonia (inability to feel pleasure)

• Difficulty concentrating

• Restlessness or impatience

• Strong cravings for nicotine

Physical symptoms

• Increased appetite or weight gain

• Insomnia or sleep disturbance

• Fatigue or low energy

• Headaches

• Coughing or throat irritation (as cilia in lungs begin to heal)

• Gastrointestinal discomfort

• Bradycardia (slowing of heart rate after stopping stimulatory effects)

The intensity and duration of withdrawal can vary depending on nicotine dose, type of product used, genetics, comorbid mental health conditions, and stress levels.

Evidence-Based Methods to Lessen Withdrawal

1. Self-Care and Behavioral Strategies

• Structured routines: Predictable schedules reduce impulsive cravings.

• Physical activity: Even brief aerobic exercise (10–20 minutes) can reduce cravings and improve mood.

• Mindfulness and breathing-based stress reduction: Proven to decrease craving intensity and improve emotional regulation.

• Hydration and oral substitutes: Water, sugar-free gum, or hard candy can reduce oral cravings.

• Sleep hygiene: Regular sleep times, limiting caffeine late in the day, and wind-down routines help manage insomnia.

• Trigger management: Avoiding early cues (alcohol, certain social settings, stressful tasks) significantly reduces relapse risk.

• Social support: Support groups or online cessation programs improve success rates.

2. Pharmacologic Treatments

Broadly, the following therapies blunt withdrawal by partially replacing nicotine or modulating neurotransmission. According to research, success rates vary.

• Nicotine Replacement Therapy (NRT): Patches, gum, lozenges, inhalers, and nasal sprays contain nicotine and are meant to replace cigarettes or a vape. Combination therapy (e.g., patch and short-acting type of nicotine) is more effective than single-agent use.

• Varenicline: This prescription pharmaceutical is a a partial agonist that targets nAChR, which reduces cravings and blocks nicotine’s reinforcing effects. T

• Bupropion SR: This prescription antidepressant is a norepinephrine–dopamine reuptake inhibitor that reduces withdrawal-related mood symptoms and cravings.

Together, behavioral strategies and medication significantly increase comfort during withdrawal and double or triple quit success rates.

References

Jackson KJ, Muldoon PP, De Biasi M, Damaj MI. New mechanisms and perspectives in nicotine withdrawal. Neuropharmacology. 2015 Sep;96(Pt B):223-34. doi: 10.1016/j.neuropharm.2014.11.009. Epub 2014 Nov 26. PMID: 25433149; PMCID: PMC4444410.

Rigotti NA, Kruse GR, Livingstone-Banks J, Hartmann-Boyce J. Treatment of Tobacco Smoking: A Review. JAMA. 2022; 327(6): p.566. doi: 10.1001/jama.2022.0395

Tiwari RK, Sharma V, Pandey RK, Shukla SS. Nicotine Addiction: Neurobiology and Mechanism. J Pharmacopuncture. 2020 Mar 31;23(1):1-7. doi: 10.3831/KPI.2020.23.001. PMID: 32322429; PMCID: PMC7163392.

Wittenberg RE, Wolfman SL, De Biasi M, Dani JA. Nicotinic acetylcholine receptors and nicotine addiction: A brief introduction. Neuropharmacology. 2020 Oct 15;177:108256. doi: 10.1016/j.neuropharm.2020.108256. Epub 2020 Jul 29. PMID: 32738308; PMCID: PMC7554201.

Assessed and Endorsed by the MedReport Medical Review Board